LobbyingNational Coalition for Cancer Survivorship lobbying by quarter
National Coalition for Cancer Survivorship's latest lobbying report covers Q2 2026, at under $5,000. Its first report covers Q4 2022; the issues it reports most are Health Issues.
National Coalition for Cancer Survivorship
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
No lobbying spend in this period.
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $0 | 2 |
| Q1 2023 | $0 | 2 |
| Q2 2023 | $0 | 2 |
| Q3 2023 | $0 | 2 |
| Q4 2023 | $0 | 2 |
| Q1 2024 | $0 | 2 |
| Q2 2024 | $0 | 2 |
| Q3 2024 | $0 | 2 |
| Q4 2024 | $0 | 2 |
| Q1 2025 | $0 | 2 |
| Q2 2025 | $0 | 2 |
| Q3 2025 | $0 | 2 |
| Q4 2025 | $0 | 2 |
| Q1 2026 | $0 | 2 |
| Q2 2026 | $0 | 2 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$0 · 30 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES30 reports
- SENATE7 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseNational Coalition for Cancer Survivorship | $0 | 15 quarters |
| Turner & Goss | $0 | 15 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/24for Q2 | In-house | Under $5,000 |
| 07/19for Q2 | Turner & Goss | Under $5,000 |
| 04/22for Q1 | In-house | Under $5,000 |
| 04/19for Q1 | Turner & Goss | Under $5,000 |
| 01/20for Q4 2025 | In-house | Under $5,000 |
| 01/19for Q4 2025 | Turner & Goss | Under $5,000 |
| 25/10/21for Q3 2025 | In-house | Under $5,000 |
| 25/10/16for Q3 2025 | Turner & Goss | Under $5,000 |
| 25/07/17for Q2 2025 | In-house | Under $5,000 |
| 25/07/17for Q2 2025 | Turner & Goss | Under $5,000 |
| 25/04/22for Q1 2025 | In-house | Under $5,000 |
| 25/04/16for Q1 2025 | Turner & Goss | Under $5,000 |
| 25/01/21for Q4 2024 | In-house | Under $5,000 |
| 25/01/20for Q4 2024 | Turner & Goss | Under $5,000 |
| 24/10/17for Q3 2024 | Turner & Goss | Under $5,000 |
| 24/10/17for Q3 2024 | In-house | Under $5,000 |
| 24/07/15for Q2 2024 | Turner & Goss | Under $5,000 |
| 24/07/15for Q2 2024 | In-house | Under $5,000 |
| 24/04/30for Q1 2024 | In-house | Under $5,000 |
| 24/04/17for Q1 2024 | Turner & Goss | Under $5,000 |